Evidence map›Paper›PMID 42543822›Full record

ArticleJournal of peptide science : an official publication of the European Peptide Society2026

Gold Nanoparticles Coated With the Antimicrobial Peptide Os-C(W5): Anticandidal and Biological Activity.

P J Palm, R R Chirombo, C K Chiramba, J C Serem, H Taute, M van der Walt, A R M Gaspar, M J Bester

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of peptide science : an official publication of the European Peptide Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

P J PalmDepartment of Anatomy, Faculty of Health Sciences, University of Pretoria, South Africa.ORCID https://orcid.org/0000-0002-3754-2386
R R ChiromboDepartment of Anatomy, Faculty of Health Sciences, University of Pretoria, South Africa.
C K ChirambaDepartment of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, South Africa.
J C SeremDepartment of Anatomy, Faculty of Health Sciences, University of Pretoria, South Africa.ORCID https://orcid.org/0000-0001-9912-166X
H TauteDepartment of Anatomy, Faculty of Health Sciences, University of Pretoria, South Africa.
M van der WaltDepartment of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, South Africa.
A R M GasparDepartment of Biochemistry, Genetics and Microbiology, Faculty of Natural and Agricultural Sciences, University of Pretoria, South Africa.
M J BesterDepartment of Anatomy, Faculty of Health Sciences, University of Pretoria, South Africa.ORCID https://orcid.org/0000-0003-1704-0052

Funding

National Research Foundation 129781
6 · The paper itself

Abstract

Candida albicans is a critical-priority fungal pathogen due to its global burden of infection, biofilm-forming ability, and increasing drug resistance. Previously, the tick-derived antimicrobial peptide (AMP), Os-C, demonstrated antifungal, antioxidant, and nitric oxide (NO) scavenging activity. Subsequent tryptophan end-tagging produced Os-C(W

Indexed as

Antifungal AgentsAntimicrobial PeptidesCandida albicansGoldMetal NanoparticlesBiofilmsHumansMicrobial Sensitivity TestsAntifungal AgentsAntimicrobial PeptidesGoldantifungalantimicrobialgold nanoparticlespeptides

Identifiers

PMID42543822
PMCPMC13430083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.